NCT02236988 - Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 7, 2014

Primary Completion Date

September 11, 2014

Study Completion Date

September 11, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

Apremilast Immediate Release

30 mg immediate release tablets

DRUG

Apremilast Modified Release 1

75 mg oral tablet of prototype modified release (MR) 1

DRUG

Apremilast Modified Release 2

75 mg oral tablet of prototype MR 2

DRUG

Apremilast Modified Release 3

75 mg oral capsule of prototype MR 3

DRUG

Apremilast Modified Release 4

75 mg oral capsule of prototype MR 4

DRUG

Apremilast Modified Release 5

75 mg oral capsule of prototype MR 5

DRUG

Apremilast Modified Release 6

75 mg oral capsule of prototype MR 6

DRUG

Apremilast Modified Release 8

80 mg oral capsule of prototype MR 8

DRUG

Apremilast Modified Release 9

80 mg oral capsule of prototype MR 9

DRUG

Apremilast Modified Release 11

80 mg oral capsule of prototype MR 11

DRUG

Apremilast Modified Release 12

80 mg oral capsule of prototype MR 12

DRUG

Apremilast Modified Release 13

80 mg oral capsule of prototype MR 13

DRUG

Apremilast Modified Release 14

80 mg oral capsule of prototype MR 14

Trial Locations (1)

53704-2526

Covance Clinical Research Unit Inc., Madison